MiNK Therapeutics Reports Corporate Update and First Quarter 2023 Financial Results
agenT-797, an allo-iNKT cell therapy, shows clinical responses in heavily pre-treated solid tumor cancers when administered with anti-PD-1 and persists...
Year: 2023
Candel Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
NEEDHAM, Mass., May 11, 2023 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage...
New Long-Term Real-World Research Confirms Xoft Skin eBx is as Safe and Effective as Mohs Surgery
98.9% of patients treated with Xoft remained recurrence-free at a median follow-up of 7.6 years, according to recent study published...
Reneo Pharmaceuticals Reports First Quarter 2023 Financial Results
Completed enrollment of the pivotal STRIDE study; topline results anticipated 4Q 2023Raised $68.3 million in gross proceeds from a concurrent...
Interoperability, access and public-private collaboration were the most discussed topics at the Italy Healthcare Innovation Summit in Milan Italian
MILAN, Italy, May 11, 2023 (GLOBE NEWSWIRE) -- The Italy Healthcare Innovation Summit, an event organized by Bamberg Health, attracted...
GH Research Reports First Quarter 2023 Financial Results and Provides Business Highlights
DUBLIN, Ireland, May 11, 2023 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming...
Results of Pilot Study That Monitored Patients with Functional Dyspepsia, Gastroparesis and Vomiting Presented at Digestive Disease Week 2023
MOUNTAIN VIEW, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- G-Tech Medical today announced an oral presentation of an abstract entitled...
Celularity Announces Advisory Guidance From Tamer Group Regarding Anticipated 2023 Purchase Orders for Celularity Branded Halal-Certified Biomaterial Products
Celularity has been advised by the Tamer Group to expect at least $60 million to $80 million in 2023 purchase...
NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode Performed at Mayo Clinic
Evo sEEG electrodes used for brain mapping in epilepsy surgery EDEN PRAIRIE, Minn., May 10, 2023 (GLOBE NEWSWIRE) -- NeuroOne...
SomaLogic expands into China with groundbreaking Biostar Technology Limited Partnership
SomaLogic to deliver 7,000-plex SomaScan® Platform to researchers in attractive Chinese proteomics marketSHANGHAI and BOULDER, Colo., May 10, 2023 (GLOBE...
Bioventus Announces Divestiture of its Wound Business
DURHAM, N.C., May 10, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations...
VectivBio Publishes Invitation to the Annual General Meeting
BASEL, Switzerland, May 10, 2023 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel...
Optimi Health Granted Natural Health Product Site Licence By Health Canada
VANCOUVER, British Columbia, May 10, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the...
Medhealth Outlook Selects TOMI Environmental Solutions as One of the Top 10 Infection Control Solution Providers of 2023
FREDERICK, Md., May 10, 2023 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in...
IRADIMED CORPORATION Named a 2023 Best Small Company in America by Forbes
Figure1 America’s Best Small Companies for 2023 WINTER SPRINGS, Fla., May 10, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”)...
Dyadic to Participate at Two Industry Events in May
JUPITER, Fla., May 10, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology...
Milestone Scientific Announces Successful Epidural Steroid Injection Procedures Under New AMA CPT Guidelines for Artificial Intelligence (AI) Assisted Pain Management Surgery
ROSELAND, N.J., May 10, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery...
Sofwave Medical Reports First Quarter Fiscal 2023 Financial Results and Recent Business Highlights
First Quarter Revenue of $10.4M, +86% Year-Over-Year GrowthOver 125,000 Treatments Performed Since Initial Approval; Global Market Conditions Remain Favorable and Demand...
Adial Pharmaceuticals Receives Notice of Exercise from Adovate for the Acquisition of Purnovate’s Assets and Business
Adial to receive potential development and commercial milestone payments of up to $83 million on the first three compounds plus...
Assure Holdings Reports Preliminary First Quarter 2023 Financial Results
DENVER, May 10, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative...